• Find a pharmacy

Get caught up with fewer trips to the pharmacy

While other adult hepatitis B vaccines require at least 3 doses and take 6 months to complete, HEPLISAV-B offers protection with just 2 doses over 1 month.

Save time by opting for fewer doses

GETTING PROTECTED

Parents know a thing or two about follow-through, and when it comes to hepatitis B vaccination, completing all doses is critical for protection.

What do your next 6 months look like?

Family life gets full, fast. Knocking out 2 doses over 1 month with HEPLISAV-B gets you caught up sooner, so you’re not stuck trying to plan for an additional dose 6 months down the line.

Hepatitis B protection

PROTECTION
More than 95% of adults were protected after completing both doses of HEPLISAV-B in clinical trials.

Hepatitis B vaccines have demonstrated long-term protection.
SAFETY
HEPLISAV-B was well studied in clinical trials of over 10,000 patients. (That’s the largest clinical trial safety database for any hepatitis B vaccine!)

SELECT IMPORTANT SAFETY INFORMATION

The most common side effects reported by patients within 7 days of vaccination with HEPLISAV-B were pain at the site of injection (23%-39%), tiredness (11%-17%), and headache (8%-17%).

Smiling dad gives daughter a piggyback ride

Getting vaccinated can be simple

Of course you made sure your child was protected against hepatitis B. Now there’s a way for you to catch up on your own health, with HEPLISAV-B. 2 doses. 1 month. Done.
Find out how
Based on a 2018 study of 10,888 adults who began a hepatitis B vaccination series with either 2-dose HEPLISAV-B or 3-dose Engerix-B.
INDICATION & Important Safety Information

INDICATION

HEPLISAV-B is indicated for the prevention of infection caused by the hepatitis B virus in adults 18 years of age and older.

IMPORTANT SAFETY INFORMATION

If you have a history of severe allergic reaction after a previous dose of any hepatitis B vaccine, or to any ingredient of HEPLISAV-B, including yeast, do not take HEPLISAV-B.

HEPLISAV-B must be given by a medical professional, who will monitor you afterwards to check for allergic reaction.

If you are immunocompromised, or receiving immunosuppressant therapy, you may have less of an immune response to HEPLISAV-B.

Some people have hepatitis B infection without being aware of it or showing any symptoms. If you already have hepatitis B present in your body, HEPLISAV-B may not prevent hepatitis B infection.

The most common side effects reported by patients within 7 days of vaccination with HEPLISAV-B were pain at the site of injection (23%-39%), tiredness (11%-17%), and headache (8%-17%).

Please see Full Prescribing Information.

INDICATION & Important Safety Information

INDICATION

HEPLISAV-B is indicated for the prevention of infection caused by the hepatitis B virus in adults 18 years of age and older.

IMPORTANT SAFETY INFORMATION

If you have a history of severe allergic reaction after a previous dose of any hepatitis B vaccine, or to any ingredient of HEPLISAV-B, including yeast, do not take HEPLISAV-B.

HEPLISAV-B must be given by a medical professional, who will monitor you afterwards to check for allergic reaction.

If you are immunocompromised, or receiving immunosuppressant therapy, you may have less of an immune response to HEPLISAV-B.

Some people have hepatitis B infection without being aware of it or showing any symptoms. If you already have hepatitis B present in your body, HEPLISAV-B may not prevent hepatitis B infection.

The most common side effects reported by patients within 7 days of vaccination with HEPLISAV-B were pain at the site of injection (23%-39%), tiredness (11%-17%), and headache (8%-17%).

Please see Full Prescribing Information.